Exact Mass: 337.08855100000005
Exact Mass Matches: 337.08855100000005
Found 144 metabolites which its exact mass value is equals to given mass value 337.08855100000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
S-Hydroxymethylglutathione
S-Hydroxymethylglutathione is a critical component of the binding site for activating fatty acids in glutathione-dependent formaldehyde dehydrogenase activity (OMIM: 103710). Formaldehyde dehydrogenase (FDH; EC 1.2.1.1), a widely occurring enzyme, catalyzes the oxidation of S-hydroxymethylglutathione into S-formylglutathione in the presence of NAD (PMID: 2806555). S-Hydroxymethylglutathione is a critical component of the binding site for activating fatty acids in glutathione-dependent formaldehyde dehydrogenase activity. (OMIM 103710)
gamma-Glutamylcysteinylserine
gamma-Glutamylcysteinylserine is found in cereals and cereal products. gamma-Glutamylcysteinylserine is a constituent of many grasses including Triticum aestivum (wheat). Constituent of many grasses including Triticum aestivum (wheat). gamma-Glutamylcysteinylserine is found in wheat and cereals and cereal products.
2,8-Dihydroxyquinoline-beta-D-glucuronide
2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978) [HMDB] 2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978).
3-Indole carboxylic acid glucuronide
3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] 3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
6-Chloro-5-methyl-N-quinolin-4-yl-2,3-dihydroindole-1-carboxamide
6-Chloro-5-methyl-N-quinolin-5-yl-2,3-dihydroindole-1-carboxamide
O1-(2-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid
11-hydroxy-1,2,10-trimethoxy-dibenzo[de,g]quinolin-7-one|Glaunin|Glaunine
O1-(4-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid
(+)-debromodiscorhabdin A|discorhabdin A trifluoroacetic acid salt
O1-(4-Hydroxy-[3]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[3]quinolyl)-beta-D-glucopyranuronic acid
O1-(2-Hydroxy-[4]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[4]quinolyl)-beta-D-glucopyranuronic acid
dehydroevodiamine hydrochloride
Dehydroevodiamine hydrochloride is isolated from the leaves of Evodia rutaecarpa[1]. Dehydroevodiamine hydrochloride is isolated from the leaves of Evodia rutaecarpa[1].
gamma-Glutamylcysteinylserine
N-(6-Aminohexyl)-2-nitrobenzenesulfonamide Hydrochloride
2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide
7-Quinolinecarboxaldehyde, 2-[2-(3,4-dihydroxy-5-methoxyphenyl)ethenyl]-8-hydroxy-
(2R)-4-Bromo-2-[[(tert-butoxy)carbonyl]amino]butanoic acid tert-butyl ester
N-[2,3-Dihydro-2-(4-methoxybenzoyl)-1,3-dioxo-1H-inden-4-yl]acetamide
sodium,2-[N-(ethoxymethyl)-2-ethyl-6-methylanilino]-2-oxoethanesulfonate
N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide
6-Chloro-5-methyl-N-(quinolin-5-yl)indoline-1-carboxamide
2-(1-Piperidinyl)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrile
3-[(4-Fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine
H-DL-gGlu-DL-Cys(MeOH)-Gly-OH
D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials
5-Hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9,11,13(17),14-octaen-8-one
trans-5-O-(4-Coumaroyl)-D-quinate
The conjugate base of trans-5-O-(4-coumaroyl)-D-quinic acid.
N-[(3-nitrophenyl)methylideneamino]-4-oxo-1H-quinazoline-2-carboxamide
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide
(Quinolin-2-ylsulfanyl)-acetic acid (4-hydroxy-benzylidene)-hydrazide
N-(3-cyano-5-methyl-4-phenyl-2-thiophenyl)-3,5-dimethyl-4-isoxazolecarboxamide
N-(2-adamantyl)-4-bromo-1-methyl-3-pyrazolecarboxamide
4-methoxy-N-[(2-thioxo-1,2-dihydro-3-quinolinyl)methylene]benzohydrazide
N-[2-(uran-2-ylmethylsulanyl)ethyl]-2-(3-methoxyphenyl)sulanylacetamide
1-O-(1H-indol-3-ylcarbonyl)-beta-D-glucopyranuronic acid
S-(Hydroxymethyl)glutathione
An S-substituted glutathione that is glutathione in which the mercapto hydrogen has been replaced by a hydroxymethyl group.
3-Indole carboxylic acid glucuronide
An O-acyl carbohydrate obtained by formal condensation of the carboxy group of indole-3-carboxylic acid with the anomeric hydroxy group of beta-D-glucuronic acid.
ERK5-IN-5
ERK5-IN-5 (compound 4a) is an ERK5 kinase inhibitor with anticancer activity. ERK5-IN-5 exhibits good anti-proliferative activity with the IC50 value of 6.23 μg/mL for A549 cells[1].
11-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-12-one
({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylbutyl)amine
16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione
5-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2,4,7,9(17),10,12,14-octaen-6-one
4,5,17-trimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one
artabonatine e
{"Ingredient_id": "HBIN016915","Ingredient_name": "artabonatine e","Alias": "NA","Ingredient_formula": "C19H15NO5","Ingredient_Smile": "COC1=C2C(=C3C4=CC=CC=C4C5C6C3=C1CCN6C(=O)O5)OCO2","Ingredient_weight": "337.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1773","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11024193","DrugBank_id": "NA"}